Medicine
Showing 931-940 of 1,154 Results
-
Christopher Sharp, MD
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsClinical Informatics
Clinical Education
Teaching Physical Examination
Quality Improvement
Preventive Medicine -
Meera Sheffrin
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsGeriatric education
Implementation and evaluation of home-based care
Improving care for older adults with dementia -
Yelizaveta Sher, MD, FACLP
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care MedicineBioDr. Sher received her BA from UC Berkeley and MD from Washington University in St. Louis. She completed Residency in Psychiatry and Fellowship in Psychosomatic Medicine at Stanford University Medical Center. She has been a part of Psychosomatic Medicine Faculty, now a Division of Medical Psychiatry, at Stanford since 2013. Her areas of clinical and research interests include psychiatric comorbidities in patients with pulmonary disorders. In particular, she specializes in mental health of patients with cystic fibrosis as well as lung and heart transplant patients. She consults on patients hospitalized on medical and surgical units as well as sees patients in outpatient clinics. She serves as the Director of Psychiatric and Psychological Services for the Adult Cystic Fibrosis Clinic and Chief of Psychosomatic Medicine Clinic. She has published many articles and book chapters and edited several books related to her fields of interest and expertise.
-
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.